Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $86.83 in the prior trading day, Vaxcyte Inc (NASDAQ: PCVX) closed at $86.49, down -0.39%. In other words, the price has decreased by -$0.39 from its previous closing price. On the day, 2.01 million shares were traded. PCVX stock price reached its highest trading level at $87.32 during the session, while it also had its lowest trading level at $84.52.
Ratios:
Our goal is to gain a better understanding of PCVX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.88 and its Current Ratio is at 17.88. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on December 07, 2023, initiated with a Buy rating and assigned the stock a target price of $69.
Needham reiterated its Buy rating for the stock on January 03, 2023, while the target price for the stock was revised from $52 to $58.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 18 ’24 when GUGGENHIME ANDREW bought 8,000 shares for $86.50 per share.
PICKERING GRANT sold 2,366 shares of PCVX for $245,796 on Nov 07 ’24. The CHIEF EXECUTIVE OFFICER now owns 137,398 shares after completing the transaction at $103.89 per share. On Nov 07 ’24, another insider, PICKERING GRANT, who serves as the Officer of the company, bought 2,366 shares for $104.08 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCVX now has a Market Capitalization of 10779853824 and an Enterprise Value of 8669685760.
Stock Price History:
The Beta on a monthly basis for PCVX is 0.98, which has changed by 0.71059895 over the last 52 weeks, in comparison to a change of 0.2936039 over the same period for the S&P500. Over the past 52 weeks, PCVX has reached a high of $121.06, while it has fallen to a 52-week low of $48.24. The 50-Day Moving Average of the stock is -21.44%, while the 200-Day Moving Average is calculated to be 4.28%.
Shares Statistics:
The stock has traded on average 1.15M shares per day over the past 3-months and 2048300 shares per day over the last 10 days, according to various share statistics. A total of 124.64M shares are outstanding, with a floating share count of 120.20M. Insiders hold about 3.56% of the company’s shares, while institutions hold 107.24% stake in the company. Shares short for PCVX as of 1730332800 were 8926077 with a Short Ratio of 7.79, compared to 1727654400 on 9651135. Therefore, it implies a Short% of Shares Outstanding of 8926077 and a Short% of Float of 8.140001.
